ocr: Country Reference Randomization Patients Result Comment Hong Kong 191 Cisplatin 120 mg/m versus 60 mg/me 65 Increased Nonuniform staging and survival for low statistical power high dose United States 192 100 mg/m cisplatin plus 1000 mg/m 485 No diflerence Dose intensity of cyclophosphamide X 4 cycles versus 50 ins survival cisplatin doubled mg/m" cisplatin plus 500 mg'm- cyclophosphamide X 8 cycles Italy 193 751 mg/m- cisplatin every 3 wk X 6 cycles 295 No difference Dose intensity of versus 50 mg/m- weekly X 8 cycles in survival cisplatin doubled Italy 194 100 mg/m or 50 mg/m cisplatin plus 1 ...